[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
November 16, 2011

The Cardiovascular Biomarker ConundrumChallenges and Solutions

Author Affiliations

Author Affiliations: Department of Medicine and Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

JAMA. 2011;306(19):2151-2152. doi:10.1001/jama.2011.1673

Defined broadly, a biomarker is a physiological variable that can be measured objectively and reliably1 and connotes some biological characteristic about the patient in whom it is measured. As such, biomarkers either can be used as a surrogate for a hard end point, correlating with an important clinical outcome of interest, or can be used to provide prognostic information—predictive of future events and, at their best, a tool to influence treatment strategies. In this commentary, we argue that this latter use is the most appropriate application for biomarkers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×